title: Preparing for the arrival of "pink Viagra": strengthening Canadian direct-to-consumer information regulations.
authors.affiliation: Bioethics Program, Department of Social and Preventive Medicine, School of Public Health, Université de Montréal; and Institut de recherche en santé publique de l'Université de Montréal, Montréal, Que. jean-christophe.belisle.pipon@umontreal.ca.
authors.forename: Jean-Christophe Bélisle
authors.initials: JB
authors.lastname: Pipon
authors.affiliation: Bioethics Program, Department of Social and Preventive Medicine, School of Public Health, Université de Montréal; and Institut de recherche en santé publique de l'Université de Montréal, Montréal, Que.
authors.forename: Bryn
authors.initials: B
authors.lastname: Williams-Jones
mesh_terms: D001562:Benzimidazoles / Q000627:therapeutic use*; D002170:Canada / Q000453:epidemiology; D000067088:Direct-to-Consumer Advertising / Q000331:legislation & jurisprudence* / Q000592:standards; D017277:Drug Approval; D005260:Female; D006801:Humans; D017697:Premenopause; D063507:Sexism; D012735:Sexual Dysfunction, Physiological / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D001562:Benzimidazoles; C098107:flibanserin